idiopathic aplastic anemiainherited bone marrow failure syndromesAplastic anaemia (AA) is a rare and heterogeneous disorder. AA results in pancytopenia and a hypocellular bone marrow in the absence of an abnormal infiltrate, major dysplasia or marrow fibrosis. In children, most cases are idiopathic ...
Current management of severe acquired aplastic anemia. Overall survival in severe aplastic anemia has markedly improved in the past four decades due to advances in stem cell transplantation, immunosuppressive t... Scheinberg,Phillip - 《Einstein》 被引量: 0发表: 2011年 Management of the refractory ...
The objective of this review is to assess the base of evidence for the common practice and the current guidelines for the management of aplastic anemia. It focuses on data obtained from systematic reviews and meta-analyses of RCTs conducted in this field. Specifically, it focuses on four major...
Marsh JC. Management of acquired aplastic anemia. Blood Rev. 2005; 19 :143–151. [ PubMed ]Marsh JCW. Management of acquired aplastic anaemia. Blood Rev. 2005;19:143-151.E. C.Gordon-Smith, J. C. W.Marsh. (2000) Management of Acquired Aplastic Anemia. Reviews in Clinical and ...
Fonseca, R, Tefferi, A (1997) Practical aspects in the diagnosis and management of aplastic anemia. Am J Med Sci 313: pp. 159-69Fonseca R, Tefferi A. Practical aspects in the diagnosis and management of aplastic anemia. Am J Med Sci 1997; 313: 159-169....
Allogeneic bone marrow transplantation is the treatment of choice for young patients with severe aplastic anemia. Immunosuppressive therapy with antithymocyte globulin (ATG) and cyclosporine is used when transplantation is not the initial therapeutic choice; it induces responses in 65% to 80% of ...
Annotation aplastic crisis in haemolytic anaemias: the role of a parvovirus-like agent. Br J Haematol... LR Davis - 《British Journal of Haematology》 被引量: 8发表: 2010年 The Relationship of T-Lymphocyte Subsets and Symptom Complex Groups of Patients with Chronic Aplastic Anemia The T-...
Bessho M, Hirashima K, Asano S, Ikeda Y, Ogawa N, Tomonaga M, Toyama K, Nakahata T, Nomura T, Mizoguchi H, Yoshida Y, Niitsu Y, Kohgo Y. Treatment of the anemia of aplastic anemia patients with recombinant human erythropoietin in combination with granulocyte colony-stimulating factor: a...
Summary Anemia in oncology is the most common hematological morbidity with incidence ranging from 30–90%. Cancer-related anemia is typically multifactorial; it can be secondary to cancer itself or cancer treatment or co-existent morbidities independent of cancer. Anemia has been recognized as an ind...
Paraneoplastic syndromes are common complications of lung cancer. Although most frequently associated with advanced disease, paraneoplastic syndromes may a